As far as diabetic retinopathy is concerned, at present continuous subcutaneous insulin infusion (CSII) therapy is not capable of influencing the course of diabetic retinopathy (pre-proliferative and proliferative) observed under conventional therapy. It is controversial whether or not in some cases CSII is related to deterioration of ophthalmological findings at least for certain periods. While improved control seems not to change the course of diabetic nephropathy, diabetic neuropathy often showed amelioration of certain symptoms.
Insulin delivery systems and intensified conventional insulin therapy
Improved long-term metabolic control might be obtained by intensified conventional insulin therapy and continuous subcutaneous insulin infusion in the majority of cases, while certain cases of brittle-type diabetes may benefit from IV or IP routes of administration. Implantation of insulin infusion devices is still in the experimental stage and its clinical benefit also remains to be proven. CSII is also used by gynaecologists for control of diabetic pregnancy.
The artificial endocrine pancreas, on the other hand, is of value clinically in increasing frequency in intensive care units for perfect normalization of blood glucose, under the extreme conditions in the operating theatre, and in a number of other conditions listed in the report of this Study Group for 1982. For scientific purposes, glucose clamp studies and continuous blood glucose monitoring were reported by several groups. Studies on pulsatile versus continuous insulin infusion have shown the advantages and disadvantages of the two alternatives.
Registry of external insulin pumps
There were attempts in both the United States and Europe to establish a registry of patients treated by intensified insulin therapy and continuous infusion as far as complications and death are concerned. In the United States, out of 1065 patients observed from 1978 to 1982 Dr. Teutsch from the Center of Disease Control, Atlanta (as invited speaker) reported 35 deaths, from whom two were clearly related to pump therapy (hypoglycaemia, bacterial endocarditis), while the remainder await further clarification. Out of 202 cases treated for at least 3 months with an insulin pump reported by the Study Group of the EASD from 20 European centres, hypoglycaemia leading to unconsciousness was observed 46 times in 19 patients out of 176 treated by subcutaneous insulin infusion (or in 11%). Blood glucose values below 2.9 mmol/1 were observed 3 832times in 55412patient days with an average of four blood glucose self-determinations/day. Two not directly pump-related deaths were assessed by the survey (myocardial infarction, rupture of a cerebral aneurysm), whereas out of the discussion two fatalities (hypoglycaemia, alcoholism, poor primary care) with probable connection to this therapy were reported. The incidence of low blood glucose values under intensified insulin therapy may even be greater as only continuous blood glucose monitoring can determine all episodes with certainty.
Pancreas and islet transplantation
By invitation, Dr. D.E.R. Sutherland, Minneapolis, reported on the registry of the world's experience as of 31 December, 1982. 257 pancreas transplantations in 240 patients had been performed. At present, 43 grafts are still functioning; the longest duration in two cases being 4.5 years. Of the 43 grafts, 21 have been working longer than one year, and 22 for less than one year. Most of recent transplantations were done by pancreas segments. Mostly the duct-injection technique was used. In 20 cases pancreas and kidney were simultaneously grafted; in 62 cases pancreas was grafted prior to or following kidney transplantation.
As to immunosuppressive drugs, the use of Cyclosporin A has increased. In several cases, the development of lymphoproliferative disease was observed when Cyclosporin A was used along with anti-lymphocytic globulin. From the survey it became clear that the majority of pancreas grafts was performed in a few centres: 135 transplantations in the USA (four centres with more than five transplantations), and 122 in Europe (six centres with more than five transplantations).
The number of transplantations per year is constantly increasing 14 in 1978, 39 in 1980, 67 in 1982 . Clinical observations in a few cases indicate that vision of the graft recipient or neural function might improve. However, statistical data are not available. Histological evaluation in one case showed unchanged basement membrane thickness (but mesangial space normalized). No further attempts at islet transplantation in men were made.
As to experimental islet transplantation, the yield and the rejection were discussed, isolation techniques were tried while more experiences in larger animals and men are lacking. Refinement of collagenase digestion might lead to greater yields.
If reliable markers to assess the vascular risk in diabetes were available in the future, the patients with a high risk should be selected predominantly to undergo pancreas or islet transplantation in an early stage.
Formulation and pharmacokinetics of insulin
As the interaction of insulin with the infusion pump and catheter materials, under elevated temperatures and shaking conditions, can affect the insulin characteristics, both device and insulin must be considered as entity for testing an application. The problem of pump insulin still awaits further basic investigation and improvement.
The next meeting will take place from 5 to 7 February 1984, in Igls, Austria
